Clinical Trials
16 trialsNCT06843967 2026-05-22
A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
Memorial Sloan Kettering Cancer Center
Phase 1/2 Recruiting
NCT06239272 2026-05-19
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
St. Jude Children's Research Hospital
Phase 1/2 Recruiting
NCT06881992 2026-05-18
Tumor HI
Rezolute
Phase 3 Recruiting
NCT07089992 2026-05-14
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT06541262 2026-04-09
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Milton S. Hershey Medical Center
Phase 1/2 Recruiting
NCT04715191 2026-04-06
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Baylor College of Medicine
Phase 1 Recruiting
NCT07432932 2026-02-25
PANTHR-S
Royal Marsden NHS Foundation Trust
Recruiting
NCT07148050 2026-02-17
IMPACT
Seattle Children's Hospital
Phase 1 Recruiting
NCT07377747 2026-01-30
ReLaPSe
Australia and New Zealand Sarcoma Association
Recruiting
NCT07169344 2026-01-28
PROSARC-1
Oslo University Hospital
Phase 2 Recruiting
NCT07173972 2026-01-28
PROSARC-2
Oslo University Hospital
Phase 2 Recruiting
NCT06849986 2026-01-08
TAIS
Fudan University
Phase 2 Recruiting
NCT06198296 2025-11-03
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Baylor College of Medicine
Phase 1 Recruiting
NCT06389799 2025-08-28
PERELI
Lund University Hospital
Phase 2 Recruiting
NCT04224064 2025-02-12
ESPACE
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Recruiting
NCT02275286 2023-05-31
TRASTS
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2 Recruiting